Abstract
MDS-462 Response to Erythropoiesis-Stimulating Agent Therapy in IPSS-R Lower Risk Myelodysplastic Syndrome Patients Restratified According to IPSS-M
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have